Organon & Co. & Sun Pharma
5 shared events · Importance 3 · Last updated May 21, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Business
Organon & Co.: Organon shareholders approved the proposed acquisition by Sun Pharma, which is on track to close in early 2027, expected to strengthen Sun's specialty portfolio.
Sun Pharma: Sun Pharma reported a 27% rise in Q1 net profit and 10.5% revenue growth, driven by India and innovative medicines, while US generics declined. The company is progressing on its Organon acquisition, expected to close in early 2027.
Jul 31, 2026 · 7 articles
Business
Organon & Co.: Acquired by Sun Pharma in 2026; mentioned as comparable deal.
Sun Pharma: Mentioned as part of 2026 M&A activity; acquired Organon for $11.75B.
Jul 06, 2026 · 34 articles
Business
Organon & Co.: Organon & Co. is the target of a significant acquisition by Sun Pharma, showcasing outbound M&A from India.
May 21, 2026 · 6 articles
ERGEN INTELLIGENCE
Explore this relationship live
Track how Organon & Co. and Sun Pharma interact across events, view sentiment trends, and discover connected entities.
Open Dashboard